Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14847 total
Eli Lilly and Company enters the final three weeks before its Q3 print with the analyst upgrade cycle accelerating, short interest still negligible, and the stock trading roughly 13% below a consensus target that keeps…
LEN enters the final stretch of 2026 with two forceful hands pulling in opposite directions: Berkshire Hathaway buying aggressively into weakness while short sellers and analysts line up on the other side. The…
Landstar System heads into its October 27 quarterly results with the Street's price targets falling fast and the stock trading well below where most analysts think it should be. The analyst angle is the dominant story…
Johnson & Johnson arrives at its October 13 earnings date having shed nearly 5% over the past week, with the Street busy raising price targets even as the stock pulls back. The analyst community has been notably active…
JBLU heads into its October 27 earnings print as one of the most heavily shorted names in the airline sector, with the stock down 13% over the past month and analysts cutting targets across the board. Short sellers…
Intuitive Surgical heads into its October 20 earnings report with a fresh Barclays initiation pulling in the same direction as the broader Street consensus, even as the stock trades 15% below the average analyst target…
International Paper enters its October 28 earnings date in an uncomfortable position: the stock has shed 14% over the past month, analysts who lifted targets after July's results are now walking them back, and short…
IFF heads into its November earnings with short sellers pulling back sharply and at least one analyst marking up their view, yet the stock itself is drifting lower on the month. The most striking development this week…
Intel heads into the final stretch before its Q3 earnings report with the stock down a further 3% on the week, shorts adding positions at a measured pace, and the Street anchored near neutral despite a handful of…
IMAX heads into its October 23 earnings date with short sellers rebuilding positions, the stock down 10% on the week, and an activist on the share register, all while the analyst community stays firmly bullish. The…
Illumina heads into its October 30 earnings with a sharp divergence at its core: short sellers have been covering steadily for weeks, yet options traders turned their most defensive in a year on the very day the stock…
J.B. Hunt Transport Services heads into its October 15 earnings release with analysts broadly trimming price targets and the stock down 17% over the past month to $225.93, setting up a rare disconnect between Street…
HUM enters the final stretch before its November 6 earnings with analyst sentiment shifting meaningfully in its favour, a sharp contrast to the cost-pressure narrative that dominated the stock for much of the year. The…
HRL heads into early October with the stock near multi-year lows, a director buying the dip with his own cash, and BNP Paribas trimming its target again just this week, a split verdict that captures the tension around…
HP enters October with an interesting tension: the Street has grown meaningfully more constructive on Helmerich & Payne over the past few weeks, yet the stock has given back 11% over the past month to close at $39.61,…
HCSG heads into its October 20 earnings release with two sharp one-day moves in the same direction: short interest jumped 29% on Tuesday and the put/call ratio hit its highest level of the past year, both on the same…
GILD heads into its November 6 earnings date with a curious split: the Street turned more constructive on Wednesday, yet the stock shed nearly 5% on the week to close at $144.23, leaving analysts collectively pointing…
Arthur J. Gallagher & Co. heads into its October 29 results with a cluster of analyst target cuts arriving all at once and a stock that has already shed 12.5% over the past month to $229.85. The Street story this week…
FuelCell Energy has become one of the most charged setups in the clean energy space, with more than half the free float sold short even as the stock rips 22% higher in a single week. The short interest story here is…
FCX heads into its October 23 earnings report with a wave of analyst upgrades and a short position that has quietly doubled since early September, creating an unusual backdrop where institutional conviction is rising…
